PHASE-II EVALUATION OF BISANTRENE IN REFRACTORY MULTIPLE-MYELOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY

被引：0
|
作者：
DURIE, BGM
CROWLEY, J
COLTMAN, CA
CHAPMAN, RA
BALCERZK, SP
BONNET, JD
LIPSCHITZ, DA
STEPHENS, RL
CHESON, BD
机构：
[1] UNIV ARKANSAS MED SCI HOSP,LITTLE ROCK,AR 72205
[2] UNIV KANSAS,MED CTR,KANSAS CITY,KS 66103
[3] UNIV UTAH,MED CTR,SALT LAKE CITY,UT 84112
[4] UNIV ARIZONA,CTR CANC,TUCSON,AZ 85721
[5] SW ONCOL GRP,CTR STAT,SEATTLE,WA
[6] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX 78284
[7] HENRY FORD HOSP,DETROIT,MI 48202
[8] OHIO STATE UNIV,CTR HLTH,COLUMBUS,OH 43210
[9] SCOTT & WHITE MEM HOSP & CLIN,TEMPLE,TX
来源：
INVESTIGATIONAL NEW DRUGS | 1991年 / 9卷 / 04期
关键词：
BISANTRENE; MYELOMA;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：329 / 331
页数：3
相关论文
共 50 条
  • [1] PHASE-II TRIAL OF MITOXANTRONE IN MULTIPLE-MYELOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    ALBERTS, DS
    BALCERZAK, SP
    BONNET, JD
    STEPHENS, RL
    CANCER TREATMENT REPORTS, 1985, 69 (11): : 1321 - 1323
  • [2] PHASE-II TRIAL OF DIAZIQUONE IN PATIENTS WITH REFRACTORY AND RELAPSING MULTIPLE-MYELOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    STUCKEY, WJ
    CROWLEY, J
    BAKER, LH
    LARRIMER, NR
    HANSON, KH
    BONNET, JD
    WHITE, LA
    CANCER TREATMENT REPORTS, 1987, 71 (11): : 1095 - 1096
  • [3] PHASE-II STUDY OF FLUDARABINE PHOSPHATE IN MULTIPLE-MYELOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    KRAUT, EH
    CROWLEY, JJ
    GREVER, MR
    KEPPEN, MD
    BONNET, JD
    HYNES, HE
    SALMON, SE
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (02) : 199 - 200
  • [4] PHASE-II EVALUATION OF BISANTRENE IN ACUTE-LEUKEMIA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    MILLS, GM
    DAHLBERG, S
    COWAN, J
    NEILAN, BA
    GUMBART, CH
    HUSSEIN, K
    COLTMAN, CA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (06): : 507 - 510
  • [5] PHASE-II TRIAL OF BISANTRENE IN HEPATOCELLULAR-CARCINOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    BROWN, TD
    FLEMING, TR
    SHILDT, RA
    COWAN, JD
    CANCER TREATMENT REPORTS, 1987, 71 (11): : 1101 - 1102
  • [6] PHASE-II TRIAL OF BISANTRENE IN PATIENTS WITH ADVANCED SARCOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    COWAN, JD
    GEHAN, E
    RIVKIN, SE
    JONES, SE
    CANCER TREATMENT REPORTS, 1986, 70 (05): : 685 - 686
  • [7] A PHASE-II EVALUATION OF TAMOXIFEN IN UNRESECTABLE OR REFRACTORY MENINGIOMAS - A SOUTHWEST ONCOLOGY GROUP-STUDY
    GOODWIN, JW
    CROWLEY, J
    EYRE, HJ
    STAFFORD, B
    JAECKLE, KA
    TOWNSEND, JJ
    JOURNAL OF NEURO-ONCOLOGY, 1993, 15 (01) : 75 - 77
  • [8] PHASE-II INVESTIGATION OF PENTOSTATIN IN MULTIPLE-MYELOMA - A SOUTHWEST-ONCOLOGY-GROUP-STUDY
    GREVER, MR
    CROWLEY, J
    SALMON, S
    MCGEE, R
    KRAUT, EH
    BUYS, SS
    RIVKIN, SE
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (22) : 1778 - 1779
  • [9] PHASE-II EVALUATION OF MAYTANSINE IN REFRACTORY NON-HODGKINS LYMPHOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    RATANATHARATHORN, V
    GADELMAWLA, N
    WILSON, HE
    BONNET, JD
    RIVKIN, SE
    MASS, R
    CANCER TREATMENT REPORTS, 1982, 66 (07): : 1587 - 1588
  • [10] PHASE-II EVALUATION OF CHLOROZOTOCIN IN REFRACTORY MULTIPLE-MYELOMA
    FORMAN, WB
    COHEN, HJ
    BARTOLUCCI, AA
    MANNING, G
    CANCER TREATMENT REPORTS, 1984, 68 (11): : 1409 - 1410
12345